Recombinant human Factor VIIa
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Recombinant human Factor VIIa, covering 2025-08-15 to 2025-08-15. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Assess the Reversal of the Anticoagulant Effects of Milvexian by 4-Factor Prothrombin Complex Concentrate (4F-PCC) (Part 1) and Recombinant Human Factor VIIa (rFVIIa) (Part 2) in Healthy Participants [Phase 1]